News

Speaking ahead of the eyeforpharma Barcelona 2015 conference, Alberto Grua, CCO at Grünenthalechoed similar industry commitments to putting patient’s needs to the forefront of their decision making, and

The Phase II results showed that mipsagargin appears to be effective and is well-tolerated by HCC patients. Mipsagargin targets the enzyme prostate-specific membrane antigen (PSMA), which is highly

The company said that advancement to the predictive biomarker expansion stage triggered a $5m milestone from its partner GlaxoSmithKline (GSK). The expansion stage of the anti-Notch1 Phase Ia

The deal is expected to strengthen Sanofi’s manufacturing capacity to support upcoming product launches. Currently, 72% of Sanofi’s research and development (R&D) projects are in biologics, nearly half

A provisional patent application is a legal document which establishes an early priority date for the benefit of claiming "first to file" status against other companies or individuals

CBD or Cannabidiol has been at the forefront of the news lately in its application to treat pediatric epilepsy, autism, cancer, pain, PTSD, brain injuries, anxiety, and various

With the construction of WCCT Global’s influenza challenge facility in Costa Mesa, California, the CRO has the capability to conduct virus challenge clinical trials in North America. WCCT

The Company also wishes to take this opportunity to better clarify the role of Hypochlorous acid in managing eyelid care. We believe that recent public statements concerning Hypochlorous

The invention relates to Crotoxin compositions for intravenous administration and methods of use of Crotoxin for the treatment of pain and/or for the treatment of neurologic and neuromuscular